A Phase 4 Clinical Trial to Evaluate the Efficacy and Safety of CANIUM Tab. in Acute Bronchitis Patients.

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This study compared two oral medicines containing Pelargonium sidoides extract in patients aged 12 to 75 years with acute bronchitis. Participants were randomly assigned to DSP2505 (Ckanium tablets) or Umckamin tablets for 7 days. The main question was whether DSP2505 was no worse than Umckamin by more than a defined margin in improving bronchitis symptoms. Symptoms, cough-related quality of life, overall improvement, satisfaction, and safety were assessed.
Epistemonikos ID: 2ddcb4d5ee2f1896161ab6b9c1dfeb4a68e317a8
First added on: Sep 24, 2026